Tuulia Vallius, Ph.D., M.D.
This page shows the publications Tuulia Vallius has written about Ovarian Neoplasms.
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer. Tumour Biol. 2017 Feb; 39(2):1010428317691189.
18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Gynecol Oncol. 2016 Jan; 140(1):29-35.
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. Tumour Biol. 2014 Dec; 35(12):12389-95.
Virtual clinical trials identify effective combination therapies in ovarian cancer. Sci Rep. 2019 12 10; 9(1):18678.
Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer. Cancer Res. 2018 07 15; 78(14):4036-4044.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.